Glycerophosphocholine (GPC) is a natural compound that can help you improve memory, focus, concentration and maintain healthy brain function during aging. GPC has been studied in over 20 clinical trails involving 4,000 patients. Results show GPC supports:
speed and sharpness of cognition
focus, concentration, and recall
revitalization of declining mental function
While GPC is not a cure for Alzheimer's disease, clinical trials have shown that it may help the brain recover some of its functions lost during aging.
A recent study demonstrated GPC's benefits against mild to moderate Alzheimer's dementia:
De Jesus Moreno Moreno M. Cognitive improvement in mild to
moderate Alzheimer's dementia after treatment with the acetylcholine
precursor choline alfoscerate: a multicenter, double-blind, randomized,
placebo-controlled trial. Clin Ther 2003;25(1):178-93.
The researchers noted that patients improved not just on cognition, but in behavior and daily living activities.
Another study demonstrated GPC's ability to support the brain after a stroke or brain injury:
Barbagallo Sangiorgi G, Barbagallo M, Giordano M, Meli M,
Panzarasa R. alpha-Glycerophosphocholine in the mental recovery of
cerebral ischemic attacks. An Italian multicenter clinical trial. Ann N Y
Acad Sci 1994;717:253-69.
Panzarasa R. alpha-Glycerophosphocholine in the mental recovery of
cerebral ischemic attacks. An Italian multicenter clinical trial. Ann N Y
Acad Sci 1994;717:253-69.
In all, five trials have been published in which GPC was successfully used to enhance stroke recovery in 2,972 patients.
Phosphatidyl Serine (PS) is a nutrient natural to the brain's biochemistry. PS is documented through more than twenty double-blind trials. PS can mildly improve personality, sociability, and the activities of daily living in some persons with severe cognitive breakdown.
For ordering information email us here.
Posts
1 comment:
Clinical studies that test potential new treatments are the best chance we have for fighting Alzheimer’s Disease. Current therapies treat the symptoms associated with it, not the disease itself. The goal of the ICARA Study is to explore if an investigational drug, called bapineuzumab, can help slow the progression of Alzheimer's. It is important for patients and families affected by Alzheimer's to consider participating in clinical studies. Patients and families affected by Alzheimer’s can visit www.icarastudy.com to see if they’re eligible to enroll.
Post a Comment